Analgesics in Macedonia
ANALGESICS IN MACEDONIA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Self-medication Trend Grows As Consumers Skip Visits To the Doctor
Systemic Analgesics Continues To Outperform Topical Analgesics/anaesthetic
Growing Popularity of Paediatric Analgesics
Competitive Landscape
Alkaloid Ad Skopje Continues To Dominate Analgesics
Bayer Pharma and Krka Farma the Leading International Manufacturers
Alkaloid's Strong Value Share Helps Domestic Companies To Dominate Analgesics
Category Data
Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Continues To Record Steady Growth Despite Political Turbulence
Internet Access and Social Media Platforms Support the Growing Self-medication Trend
Consumer Health in Macedonia Dominated by International Manufacturers
Few Channels Sell Consumer Health Products Beyond Chemists/pharmacies
Healthy Growth of Consumer Health Expected To Continue Over the Forecast Period
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
In 2018, increasing self-medication continued to positively impact most consumer health categories. Analgesics in particular continued to benefit from this trend as many local consumers are trying to avoid trips to the doctor and other medical professionals. This behaviour enabled analgesics to continue to post steady growth. The ageing population is also helping drive demand for analgesics, although negative demographics trends are beginning to adversely impact the category as its consumer base...
Euromonitor International's Analgesics in Macedonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.